Eterna Therapeutics Inc. Revenue 2010–2024
Eterna Therapeutics Inc. annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Eterna Therapeutics Inc. revenue for the quarter ending September 30, 2024 was 487000, a 854.90% increase year-over-year.
- Eterna Therapeutics Inc. revenue for the twelve months ending September 30, 2024 was 632000, a 71.67% decrease year-over-year.
- Eterna Therapeutics Inc. annual revenue for 2024 was 582000, a 755.88% increase from 2023.
- Eterna Therapeutics Inc. annual revenue for 2023 was 68000.
- Eterna Therapeutics Inc. annual revenue for 2022 was 0, a 100.00% decrease from 2020.
- Eterna Therapeutics Inc. annual revenue for 2020 was 5.8 M.
Eterna Therapeutics Inc. (ERNA) — Frequently Asked Questions
Eterna Therapeutics Inc. (ERNA) is a publicly traded US company. It has a market capitalization of $6M. In fiscal 2024 it reported revenue of $582,000 and net income of -$45M. Explore ERNA's stock price, financial statements, earnings history, margins and key ratios below.
What is Eterna Therapeutics Inc.'s market cap?
Eterna Therapeutics Inc. (ERNA) has a market capitalization of $6M.
What is the ERNA stock price?
ERNA trades at $6.34 (-6.76% on the day).
How much revenue does Eterna Therapeutics Inc. make?
Eterna Therapeutics Inc. reported revenue of $582,000 in fiscal 2024.
Is ERNA profitable?
In fiscal 2024, Eterna Therapeutics Inc. reported net income of -$45M.